Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force
暂无分享,去创建一个
Orion J. Buske | Anne R. Pariser | J. Pastor | D. Taruscio | A. Pariser | S. Groft | D. Julkowska | T. Klopstock | K. Nielsen | Harumasa Nakamura | E. Davies | G. Zanello | L. Black | R. Nabbout | Yeonju Kim | I. Brambilla | M. Scarpa | Dixie Baker | Laurie S. Conklin | Jose Carlos Pastor | Maureen Smith | Daria Julkowska
[1] Tudor I. Oprea,et al. How many rare diseases are there? , 2019, Nature Reviews Drug Discovery.
[2] A. Olry,et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database , 2019, European Journal of Human Genetics.
[3] R. Gibbs,et al. A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers , 2019, Cell.
[4] Murim Choi,et al. The Korean undiagnosed diseases program: lessons from a one-year pilot project , 2019, Orphanet Journal of Rare Diseases.
[5] Peter N. Robinson,et al. International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases , 2017, American journal of human genetics.
[6] W. Gahl,et al. Enhancing the value of clinical networks for rare diseases , 2022, Rare Disease and Orphan Drugs Journal.
[7] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..